Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02825836
Title Phase I/II, First in Human, Dose Escalation Trial of TL 895 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Relapsed/Refractory Small Lymphocytic Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Telios Pharma, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR

Facility Status City State Zip Country Details
Ohio State University Wexner Medical Center Columbus Ohio 43210 United States Details
The West Clinic Germantown Tennessee 38138 United States Details
Debreceni Egyetem - Borgyógyászati Klinika Debrecen 4002 Hungary Details
Eger Markhot Ferenc Kórház Eger 3300 Hungary Details
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi - Istituto di Ematologia e Oncologia Medica Bologna 40138 Italy Details
Examen sp. z o. o. Skorzewo Poznań 60-185 Poland Details
Pratia MCM Krakow Krakow 30-510 Poland Details
Centrum Onkologii Ziemi Lubelskiej im sw Jana z Dukli Oddzial Hematologiczny Lublin 20-090 Poland Details
Szpital Wojewódzki Opole 46-020 Poland Details
Nasz Lekarz Przychodnie Medyczne Toruń 87-100 Poland Details
Saint Petersburg State Medical University Saint Petersburg 197022 Russian Federation Details
Yaroslavl Regional Clinical Hospital Yaroslavl 150023 Russian Federation Details
Communal Non-profit Enterprise Regional Center of Oncology Kharkiv 61000 Ukraine Details
Kyiv City Clinical Hospital #4 Kyiv 03110 Ukraine Details
Mykolaiv Regional Clinical Hospital Mykolaiv 54058 Ukraine Details
University College London Hospitals - NIHR/Wellcome Trust London United Kingdom Details
Derriford Hospital - Dept of Haematology Plymouth United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field